Ranitidine
- Product NDC
- 65162-254
- 11-digit product format
- 651620254
- Labeler code
- 65162
- Product ID
- 65162-254_e0ba270f-8460-4853-ae5d-6416a7b9cb79
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranitidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- ANDA077824
- Marketing category
- ANDA
- Marketing start
- 2009-12-16
- Marketing end
- 0000-00-00
- Substance
- RANITIDINE HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65162-254 | RANITIDINE TABLET [AMNEAL PHARMACEUTICALS LLC] | 7 | Legacy NDC | 20241031_9f416ce0-012f-4194-9382-74ac71e4b2a9.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65162-254-03 | 65162025403 | 30 TABLET in 1 BOTTLE (65162-254-03) | 30 tablet | 2009-12-16 | 0000-00-00 | No | No | Current |
| 65162-254-10 | 65162025410 | 100 TABLET in 1 BOTTLE (65162-254-10) | 100 tablet | 2009-12-16 | 0000-00-00 | No | No | Current |
| 65162-254-11 | 65162025411 | 1000 TABLET in 1 BOTTLE (65162-254-11) | 1000 tablet | 2009-12-16 | 0000-00-00 | No | No | Current |
| 65162-254-25 | 65162025425 | 250 TABLET in 1 BOTTLE (65162-254-25) | 250 tablet | 2009-12-16 | 0000-00-00 | No | No | Current |